The study will pair Roche’s immune suppressor Actemra along with Gilead’s antiviral remdesivir, the only drug shown so far to fight the coronavirus, in treating patients with severe pneumonia, Roche said in a statement. The results of the combination will be compared to those from patients who receive remdesivir and a placebo.
The trial adds to the blizzard of research into existing medicines against Covid-19. While antivirals seek to stop viruses from replicating, drugs like Actemra — often used to treat rheumatoid arthritis — aim to counter harmful levels of inflammation, sometimes called a cytokine storm, that can be just as damaging as the infection itself.
Inflammation-dampening drugs aren’t without risk, since they limit the body’s ability to fight the infection, Sam Fazeli of Bloomberg Intelligence said in a note.
The best of the Muslim Times’ collection for war against Covid 19:
In this day and age, understanding bacteria and viruses and developing vaccines are national security issues. In my view sizable part of every country’s defense budget should be spent in these pursuits rather than making tanks and other weapons.
For the latest news about drugs and vaccines’ trials please go to: Pharmaceutical-Technology
For the latest health news from BBC, Please click here
The Muslim Times has the best collections in the war against Covid 19 as we are collecting from all the established sources
For the number of cases and epidemiology in each country go to: WorldOMeters
DAILY NEW CASES AND DEATHS IN US, CDC SITE